Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 107Lymphoma 48Lymphoma, Non-Hodgkin 44Hodgkin Disease 44Leukemia, Myeloid, Acute 41Myelodysplastic Syndromes 40Leukemia 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Leukemia, Lymphocytic, Chronic, B-Cell 28Lymphoma, Mantle-Cell 26Neoplasms, Plasma Cell 25Lymphoma, Large B-Cell, Diffuse 24Lymphoma, Follicular 24Lymphoma, B-Cell, Marginal Zone 18Burkitt Lymphoma 18Leukemia, Myelogenous, Chronic, BCR-ABL Positive 17Myeloproliferative Disorders 16Recurrence 14Immunoglobulin Light-chain Amyloidosis 14Congenital Abnormalities 13Primary Myelofibrosis 12Lymphoma, Large-Cell, Immunoblastic 12Leukemia, Myeloid, Accelerated Phase 12Hematologic Neoplasms 12Waldenstrom Macroglobulinemia 10Lymphoma, T-Cell, Cutaneous 10Leukemia, Myelomonocytic, Juvenile 10Leukemia, Myelomonocytic, Chronic 10Leukemia, Myeloid, Chronic-Phase 10Dendritic Cell Sarcoma, Interdigitating 10

Interventions

Sunitinib 64Nivolumab 42pembrolizumab 36Bevacizumab 32Everolimus 31Sorafenib 25pazopanib 23Axitinib 23cabozantinib 14aldesleukin 13Ipilimumab 13temsirolimus 11Interferon alpha-2 11Cyclophosphamide 10avelumab 9Magnetic Resonance Spectroscopy 9Interleukin-2 9lenvatinib 8atezolizumab 8Radiosurgery 8Gemcitabine 8Immunoglobulin G 7Erlotinib Hydrochloride 7Disulfides 6fludarabine phosphate 5Radiotherapy 5Fluorodeoxyglucose F18 5peginterferon alfa-2b 4Vorinostat 4Tyrosine Kinase Inhibitors 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Carcinoma, Renal Cell × Melphalan × Clear all
NCT00429026 2013-03-04

Conditioning Regimen in Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation

M.D. Anderson Cancer Center

Phase 2 Terminated
40 enrolled 2 charts
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡